Facultad de Medicina (FM)
Centro académico
Academic Medical Center
Ámsterdam, HolandaPublications en collaboration avec des chercheurs de Academic Medical Center (105)
2024
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387
-
Correction to: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (Blood Cancer Journal, (2024), 14, 1, (24), 10.1038/s41408-023-00966-9)
Blood Cancer Journal
-
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
New England Journal of Medicine, Vol. 390, Núm. 4, pp. 301-313
-
EUSOMA quality indicators for non-metastatic breast cancer: An update
European Journal of Cancer, Vol. 198
-
Endoscopic GI placement of capsule endoscopy to investigate the small bowel: a multicenter European retrospective series of 630 procedures in adult patients
Gastrointestinal Endoscopy, Vol. 100, Núm. 3, pp. 492-500
-
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Blood Cancer Journal, Vol. 14, Núm. 1
-
Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI)
Pediatric Research
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2706-2732
-
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
European Journal of Nuclear Medicine and Molecular Imaging
-
Propensity score-matched analysis comparing robotic versus laparoscopic minor liver resections of the anterolateral segments: an international multi-center study of 10,517 cases
Annals of Surgery
-
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
Breast, Vol. 78
-
Sex dependence of postoperative pulmonary complications – A post hoc unmatched and matched analysis of LAS VEGAS
Journal of Clinical Anesthesia, Vol. 99
-
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1016-1027
-
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
New England Journal of Medicine, Vol. 391, Núm. 1, pp. 44-55
2023
-
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
JHEP Reports, Vol. 5, Núm. 5
-
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients
Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 5, pp. 2301-2309
-
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
HPB, Vol. 25, Núm. 11, pp. 1302-1322